Axonics Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and ... Axonics Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence. Show more
Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the...
Generated record revenue, gross margin and net income in 2Q24 Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally...
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral...
Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported...
Boston Scientific Announces Results for First Quarter 2024 PR Newswire MARLBOROUGH, Mass., April 24, 2024 MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:...
Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics’ merger agreement with Boston Scientific Corporation (NYSE: BSX). According to preliminary voting...
Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two Medtronic patents that...
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.6 | 0.869565217391 | 69 | 69.6 | 68.31 | 549173 | 69.10193186 | CS |
4 | 0.51 | 0.738167607469 | 69.09 | 69.6 | 68.31 | 366513 | 69.01335617 | CS |
12 | 2.1 | 3.11111111111 | 67.5 | 69.6 | 67.2 | 331112 | 68.58543961 | CS |
26 | 1.17 | 1.70977641385 | 68.43 | 69.67 | 66.32 | 460950 | 67.97139628 | CS |
52 | 14.87 | 27.1697423716 | 54.73 | 69.68 | 48.3 | 686424 | 65.41700124 | CS |
156 | 0.53 | 0.767337483712 | 69.07 | 79.915 | 38.41 | 624419 | 61.52395047 | CS |
260 | 39.58 | 131.845436376 | 30.02 | 79.915 | 15.25 | 603290 | 54.74572846 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.